Commonwealth Scientific and Industrial Research Organisation-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Commonwealth Scientific and Industrial Research Organisation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013095
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Commonwealth Scientific and Industrial Research Organisation (CSIRO) is a national science agency that conducts research in climate adaptation, bio-security, renewable and energy, farming and food production, and information technology, and mining and manufacturing services, and others. The agency provides astronomy and space science services such as radio astronomy, spacecraft tracking and space science; and shapes the square kilometer array services, among others. It provides educational services such as science bootcamp, an immersive CSIRO science experience for secondary school students, inquire to discover, indigenous stem education program, sustainable futures and scientists and mathematicians in schools programs. The agency operates in New South Wales, Western Australian, Victoria, South Australian, Northern Territory, Queensland and Tasmania, among others. CSIRO is headquartered in Canberra, Victoria, Australia.

Commonwealth Scientific and Industrial Research Organisation – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Commonwealth Scientific and Industrial Research Organisation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Commonwealth Scientific and Industrial Research Organisation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Commonwealth Scientific and Industrial Research Organisation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Commonwealth Scientific and Industrial Research Organisation, Medical Devices Deals, 2011 to YTD 2017 8
Commonwealth Scientific and Industrial Research Organisation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Commonwealth Scientific and Industrial Research Organisation, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Resonance Health Partners with CSIRO 10
CSIRO Enters Into Co-Development Agreement With Lonza 11
Clover Enters Into R&D Agreement With CSIRO For Next Generation Of Encapsulation Technology 12
Licensing Agreements 13
Nexgenia Enters into Licensing Agreement with CSIRO 13
Commonwealth Scientific and Industrial Research Organisation – Key Competitors 14
Commonwealth Scientific and Industrial Research Organisation – Key Employees 15
Commonwealth Scientific and Industrial Research Organisation – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Commonwealth Scientific and Industrial Research Organisation, Pharmaceuticals & Healthcare, Key Facts 2
Commonwealth Scientific and Industrial Research Organisation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Commonwealth Scientific and Industrial Research Organisation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Commonwealth Scientific and Industrial Research Organisation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Commonwealth Scientific and Industrial Research Organisation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Commonwealth Scientific and Industrial Research Organisation, Medical Devices Deals, 2011 to YTD 2017 8
Commonwealth Scientific and Industrial Research Organisation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Resonance Health Partners with CSIRO 10
CSIRO Enters Into Co-Development Agreement With Lonza 11
Clover Enters Into R&D Agreement With CSIRO For Next Generation Of Encapsulation Technology 12
Nexgenia Enters into Licensing Agreement with CSIRO 13
Commonwealth Scientific and Industrial Research Organisation, Key Competitors 14
Commonwealth Scientific and Industrial Research Organisation, Key Employees 15
Commonwealth Scientific and Industrial Research Organisation, Other Locations 16

★海外企業調査レポート[Commonwealth Scientific and Industrial Research Organisation-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vermont Electric Cooperative Inc:企業の戦略的SWOT分析
    Vermont Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Petoro AS:企業の戦略的SWOT分析
    Petoro AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Corona Remedies Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Corona Remedies Pvt Ltd (Corona) is a drugs manufacturing company that develops, manufactures, and markets pharmaceutical products. The company’s products include antiallergic drugs, antibiotic drugs, analgesic drugs, antimalarial drugs, heamatonics, hormonal drugs, nutritional supplements, …
  • Gencor Industries Inc (GENC):企業の財務・戦略的SWOT分析
    Gencor Industries Inc (GENC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Pulai Group:企業の戦略・SWOT・財務分析
    Pulai Group - Strategy, SWOT and Corporate Finance Report Summary Pulai Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Furukawa Electric Co., Ltd.:企業の戦略・SWOT・財務分析
    Furukawa Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Furukawa Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Chubu Electric Power Co Inc (9502):石油・ガス:M&Aディール及び事業提携情報
    Summary Chubu Electric Power Co Inc (Chubu) is an energy utility. It generates and procures electricity; and offers electric network related services. The company produces electricity using hydro, thermal, nuclear and renewable sources. Chubu has interests in upstream and midstream energy fields. It …
  • North Eastern Electric Power Corporation Ltd-エネルギー分野:企業M&A・提携分析
    Summary North Eastern Electric Power Corporation Limited (NEEPCO) is a government owned electric utility that generates, procures and sells electricity. The company designs, constructs, operates and maintains hydro, thermal and gas projects. NEEPCO generates electricity from hydro, thermal, and sola …
  • CIMB Group Holdings Berhad:戦略・SWOT・企業財務分析
    CIMB Group Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary CIMB Group Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • InflaRx NV (IFRX):製薬・医療:M&Aディール及び事業提携情報
    Summary InflaRx NV (InflaRx) is a clinical-stage biopharmaceutical company that develops therapies in the field of acute and chronic inflammation. The company offers development of monoclonal antibodies targeting activation products of the complement system for application in threatening inflammator …
  • One Way Liver SL-製薬・医療分野:企業M&A・提携分析
    Summary One Way Liver SL (OWL), formerly One Way Liver Genomics SL is a biotechnology company that discovers, develops and offers diagnostic products and metabolomics services for the healthcare sector. The company commercializes OWLiver, which is a serum based test used for steatosis and NASH diagn …
  • Davide Campari-Milano SpA:企業の戦略・SWOT・財務情報
    Davide Campari-Milano SpA - Strategy, SWOT and Corporate Finance Report Summary Davide Campari-Milano SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Ardelyx Inc (ARDX):企業の財務・戦略的SWOT分析
    Summary Ardelyx Inc (Ardelyx) is a developer of small molecule therapeutics for treatment of cardio-renal, gastrointestinal and metabolic disorders. The company offers products such as tenapanor, and RDX013. Its products are used for hyperphosphatemia in patients with end-stage renal disease; consti …
  • JW Pharmaceutical Corp (001060):製薬・医療:M&Aディール及び事業提携情報
    Summary JW Pharmaceutical Corp (JW Pharmaceutical), a subsidiary of JW Holdings Corp is a provider of generic drugs. The company develops and markets analgesics, antipyretics and cold remedy, antidote agents, antimicrobials, anticancer agents, and others. It offers multivitamins and antianemic agent …
  • Mechel:企業の戦略・SWOT・財務情報
    Mechel - Strategy, SWOT and Corporate Finance Report Summary Mechel - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Phono Solar Technology Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Phono Solar Technology Co Ltd (Phono Solar), a subsidiary of Sumec Group Corp, is a renewable energy company that manufactures and markets solar photovoltaic panels. The company offers products such as solar generator, LED lights, solar modules, glass modules, phonocube, heating and cooling …
  • Tenaska Inc:発電所・企業SWOT分析
    Tenaska Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • University of Zurich-製薬・医療分野:企業M&A・提携分析
    Summary University of Zurich (UZH) is an educational and research university that provides bachelor, master and doctorate programs. The university offers courses in the areas of theology, law, business, economics and informatics, medicine, veterinary medicine, arts and social sciences. Its research …
  • AEI Services LLC-エネルギー分野:企業M&A・提携分析
    Summary AEI Services LLC (AEI), formerly Ashmore Energy International, is an energy utility company that owns, develops and operates power generation assets. The company also carries out the natural gas transportation and distribution businesses in emerging markets. Its power generation portfolio co …
  • Andrew Peller Limited:企業の戦略・SWOT・財務情報
    Andrew Peller Limited - Strategy, SWOT and Corporate Finance Report Summary Andrew Peller Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆